| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.47 | 1e-14 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.39 | 4e-08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 8e-06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |